Welcome to our dedicated page for Zhongchao news (Ticker: ZCMD), a resource for investors and traders seeking the latest updates and insights on Zhongchao stock.
Zhongchao Inc. (NASDAQ: ZCMD) is a Cayman Islands holding company whose PRC operating entities are described as a platform-based internet technology business focused on patients with oncology and other major diseases, as well as online medical education. The ZCMD news feed highlights how the company’s activities in China intersect with cancer care, chronic disease management, health education, and capital markets disclosures.
News about Zhongchao frequently covers patient management and medication assistance projects. Company announcements describe initiatives for breast cancer patients, lung cancer patients, and individuals with systemic lupus erythematosus, including disease management services, patient-reported outcome-based models, and free medication programs for low-income patients. These projects often involve collaborations with hospitals, pharmacies, pharmaceutical enterprises, non-profit organizations, and public health foundations.
Another recurring theme in Zhongchao’s news is its role in professional and public health education. Releases describe the MDMOOC platform for healthcare professionals, the Digital Online Education Platform for Common Diseases Clinical Diagnosis and Treatment, and partnerships with the Ximalaya audio platform to deliver cancer education series such as “Let’s Talk About Tumors.” These items illustrate how the company uses digital channels to share medical knowledge with both clinicians and the general public.
Investors following ZCMD news will also see updates on pharmaceutical services and capital market actions, including the integration of Naiditawei® (Oseltamivir Phosphate Capsules) into listed online procurement programs in multiple Chinese regions, and corporate actions such as a 1-for-10 share consolidation aimed at maintaining Nasdaq Capital Market listing compliance. For ongoing developments in these areas, the Zhongchao news page aggregates company press releases and related coverage in one place.
Zhongchao (NASDAQ: ZCMD) will complete a 1-for-8 share consolidation effective with market open on March 2, 2026, and will retain the ticker ZCMD under a new CUSIP G9897X123.
Every eight Class A or Class B ordinary shares will be consolidated into one share; pre-consolidation outstanding shares were 25,754,124 Class A and 4,999,772 Class B, resulting in approximately 3,219,267 Class A and 624,972 Class B shares post-consolidation, subject to fractional-share rounding. The consolidation aims to regain compliance with Nasdaq Rule 5550(a)(2). The action was approved by shareholders and the board on February 10, 2026.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.